Clinical trials sponsored by The First Affiliated Hospital with Nanjing Medical University

Phase breakdown

Conditions studied

Recruiting trials led by The First Affiliated Hospital with Nanjing Medical University

• A Clinical Study of Inhaled Nitric Oxide in Moderate-to-Severe Chronic Obstructive Pulmonary Disease
  NCT05896800 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 75 Years · Sex: All (male and female) · 1 location
• A Phase II Clinical Study of Treatment With Disitamb Vedotin Plus Pyrotinib in HER2-positive Early Breast Cancer
  NCT06001086 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic Cancer
  NCT07438106 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Randomized Controlled Trial of LOT-CRT Versus conventionaL BiVP in Heart Failure Patients With NICD
  NCT06061627 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• An Exploratory Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Antisynthetase Antibody Syndrome and Rheumatoid Arthritis
  NCT06613490 · Phase: Early Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• An Exploratory Clinical Study on the Safety and Efficacy of Autologous NK Cells in the Treatment of Pulmonary Nodules
  NCT07185035 · Phase: Early Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• CPVI With Modified Linear Ablation Versus CPVI in Patients With Long-standing Persistent Atrial Fibrillation (SINUS)
  NCT06516822 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 10 locations
• CSP Versus BiVP for Heart Failure Patients With RVP Upgraded to Cardiac Resynchronization Therapy
  NCT06241651 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Catheter Ablation in Atrial Fibrillation Patients With HFpEF (STABLE-SR IV Trial)
  NCT06125925 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPC
  NCT05956639 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 1 location
• Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide +ADT in the mHSPC
  NCT05983783 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: Male · 1 location
• Comparison of Segmentectomy Versus Lobectomy for Non-small Cell Lung Cancer ≤ 2 cm in the Middle Third of the Lung Field
  NCT04944563 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Different-Dose SCRT Plus CAPOX, PD-1 Blockade and IL-2 in LARC
  NCT07646639 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Dihydroartemisinin for MAFLD
  NCT07679542 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 45 Years · Sex: All (male and female) · 1 location
• Durvalumab as Consolidation Therapy in Patients With LS-SCLC Following sCRT
  NCT07309211 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes
  NCT07558863 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Dalpiciclib With Endocrine Therapy as Adjuvant Treatment in HR+/ HER2- Early Breast Cancer
  NCT06341894 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Methotrexate in Breast Cancer With Leptomeningeal Metastasis
  NCT06543992 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Trastuzumab in Breast Cancer With Leptomeningeal Metastasis
  NCT07263425 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Efficacy of Auricular Acupuncture Therapy in the Prevention of CIPN in Breast Cancer
  NCT07092111 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases
  NCT07558850 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• High Resolution Diffusion Weighted Imaging in Prostate
  NCT06636747 · Phase: Not specified · Ages: 55 Years and older · Sex: Male · 2 locations
• Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis
  NCT04592640 · Phase: Early Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Hypofractionated Radiation Fractionation in Breast Cancer Patients With Implant-Based Reconstruction
  NCT06830083 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: Female · 1 location
• Immunotheray Combined With Simvastatin and Target Therapy and Chemotharepy for Advanced Colorectal Cancer
  NCT07718490 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Lactobacillus Vaginalis Capsules for Treatment of Vulvovaginal Atrophy in Young Breast Cancer Patients
  NCT05974449 · Phase: Phase 2 · Ages: 18 Years to 45 Years · Sex: Female · 1 location
• Prospective Study on Exemption of Tumor Bed Boost Radiotherapy for pCR Patients After Breast Conserving Surgery With Neoadjuvant Therapy
  NCT07113613 · Phase: Phase 2 · Ages: 30 Years to 75 Years · Sex: Female · 1 location
• Pyrotinib in Women With High-risk in Early Stage Breast Cancer
  NCT05834764 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• RC48 Plus Bevacizumab or Pyrotinib in HER2-Positive Metastatic Breast Cancer After T-DXd Failure: A Phase II Study
  NCT07065435 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Safety and Efficacy of SC101 Via Perirenal Fat Injection for Resistant Hypertension in Patients With Moderate to Severe Chronic Kidney Disease
  NCT07483372 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Study on the Treatment of HER2-negative Breast Cancer Brain Metastases With Radiotherapy Combined With Anlotinib
  NCT07396454 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy
  NCT06461377 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase I Clinical Study
  NCT06770296 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• The Effects of Social Isolation and Social Interaction on the Risk of Dementia Progression and Brain Function in SCD (Subjective Cognitive Decline, SCD)
  NCT06335836 · Phase: Not specified · Ages: 45 Years to 85 Years · Sex: All (male and female) · 1 location
• Total Meso-rectal Excision Versus Transanal Local Excision Followed by Radiotherapy for T2N0M0 Distal Rectal Cancer
  NCT04098471 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is The First Affiliated Hospital with Nanjing Medical University recruiting for?

The First Affiliated Hospital with Nanjing Medical University is the lead sponsor of 35 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.